Intellikine Company

Intellikine is focused on the R&D of orally available small molecule drugs targeting the PI3K/mTOR pathway.
Technology: Data-driven Technologies
Industry: PharmTech
Headquarters: La Jolla, California, United States
Founded Date: 2007
Employees Number: 51-100
Funding Status: M&A

Visit Website
https://www.twitter.com/takedaoncology
Register and Claim Ownership